2 ms·
> Notably, about one-third of users stopped taking the medication during the study period. This isn't always the patient's choice—my insurance/PBM (CVS Caremar
by cptcobalt 9mo ago
> Notably, about one-third of users stopped taking the medication during the study period.
This isn't always the patient's choice—my insurance/PBM (CVS Caremark) dropped coverage for the GLP-1 that I was taking (Zepbound) and had several rounds of prior-authorization shenanigans over a few months before they approved the previous-generation GLP-1, Wegovy. Now I've had to start the ramp-up of a different medication again, which hurt and stalled progress. Evil.
- foxyv 9mo agoInsurance companies should have to refund your premium when they do this for the time period they are making a decision. It's gotten absurd how badly they are abusing patients.
- anon7000 9mo agoFrankly, it should be considered fraud.
- wincy 9mo agoI got a sleep apnea diagnosis so have that in my back pocket if they try to push me off Zepbound. I also had substantial mental health and physical side effects (like crying hysterically at 3am in the bathroom while vomiting) from that drug that I made sure my doctor documented.